French Version of the Scales of Fear of Hypoglycaemia in Children With

Status Recruiting

Clinical Trial Summary

Type 1 diabetes usually appears brutally in children or young adults. While many factors of poor glycemic balance have been identified in the literature (age, socio-cultural and socio-economic level, family structure, adherence etc.), it turns out that hypoglycemia is the most common acute complications. It would be an important physiological and psychological barrier for the patient and his parents to manage this diabetes, the latter seeking to keep the blood glucose levels above the objectives in order to avoid the occurrence of a hypoglycemia, especially nocturnal.

If there is a questionnaire currently validated as a tool to measure the fear of hypoglycemia (HFS, Hypoglycemia Fear Survey is available in three versions: L'HFS-Child (HFS-C) for children over 6 years old, HFS-Parents of Young children ( HFS-PYC) for parents of young children (under 8 years of age) and HFS-Parents (HFS-P)) for parents of children over 8 years of age, on the other hand, there are no French and no French studies have evaluated the prevalence and impact of the fear of hypoglycemia in French patients with type 1 diabetes.

It is therefore essential to use a reliable and valid tool to identify patients affected by the fear of hypoglycemia, which can be an obstacle to improve glycemic control and to an optimum quality of life. Having a tool in French and validated on the scientific level would allow to propose adapted therapeutic treatments (psychological follow-up, individual or collective sessions of therapeutic education, material assistance (sensor of blood glucose, pump with insulin stop...) In order to both improve metabolic balance while increasing the quality of life of patients by lowering secondary anxiety to hypoglycemia

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03529188
Study type	Observational
Source	University Hospital, Brest
Contact	Chantal METZ
Phone	02 29 02 00 04
Email	chantal.metz@chu-brest.fr
Status	Recruiting
Phase
Start date	August 3, 2018
Completion date	December 3, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02546401` - Comparison of Insulin's Injection Before or After the Meal in Type 1 Diabetic Patients Treated With Insulin Pump	Phase 3
Enrolling by invitation	`NCT06207838` - Transition of T1DM Patients Aged Over 65 Years Into AHCL (780G) Insulin Pump	N/A
Withdrawn	`NCT02057497` - An Exploratory Clinical Trial to Generate Whole Blood Samples for Analysing Genetic Polymorphisms	N/A
Active, not recruiting	`NCT05088616` - Native American Diabetes Project	N/A
Withdrawn	`NCT01501032` - Inpatient Evaluation of the MD-Logic Artificial Pancreas System in Patients With Type 1 Diabetes	Phase 1
Completed	`NCT01770561` - Feasibility Study of an Integrated Sensor and Infusion Set	N/A
Completed	`NCT00417131` - Imaging of Islet Transplantation With PET and MRT	N/A
Completed	`NCT03538106` - Factors Associated With Cesarean Delivery in Women With Type 1 Diabetes
Completed	`NCT01565824` - Web-based Support During Pregnancy and Early Motherhood in Women With Type 1 Diabetes (MODIAB-web)	N/A
Recruiting	`NCT04257877` - Proteomic Analysis in Paediatric Diabetes Type 1 (PAPD)
Withdrawn	`NCT01322321` - ACZ885 in Type 1 Diabetes Mellitus	Phase 2
Active, not recruiting	`NCT04794283` - Antenatal Hand Milking for Pregnant Women With Diabetes'
Completed	`NCT03842683` - CGM Precision and Glycaemic Variability
Suspended	`NCT04874532` - A Study to Improve Diabetes Management Among Adults Experiencing Severe Hypoglycemia	N/A
Terminated	`NCT00925977` - Treatment Satisfaction of Insulin Glargine Plus Insulin Apidra Compared With NPH Insulin Plus Insulin Apidra in Recently Diagnosed Type 1 Diabetes Children and Adolescents	N/A
Completed	`NCT02066350` - Cardiovascular Risk Factors After Single Pancreas Transplantation	N/A
Completed	`NCT02137174` - Home and School Visits Intervention for Children With DM TYPE 1	Phase 2/Phase 3
Completed	`NCT06365255` - National Epidemiological Study of the Possible Impact of Stress on Glycaemic Control in Patients With Type 1 Diabetes
Completed	`NCT03433677` - A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes	Phase 3
Completed	`NCT04587297` - Food Collection From Type 1 Diabetic Patients Practicing Insulin Functional Therapy

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

French Version of the Scales of Fear of Hypoglycaemia in Children With Type 1 Diabetes and Their Parents — FHS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms